GCM
DGX icon

Graham Capital Management’s Quest Diagnostics DGX Stock Holding History

Graham Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,673
Closed -$700K – 1307
2025
Q3 		$700K Buy
+3,673
New +$652K 0.01% 491
2024
Q3 		– Sell
-8,433
Closed -$1.15M – 1145
2024
Q2 		$1.15M Buy
+8,433
New +$1.15M 0.03% 379
2022
Q4 		– Sell
-2,852
Closed -$349K – 1096
2022
Q3 		$349K Buy
+2,852
New +$376K 0.01% 851
2022
Q2 		– Sell
-1,896
Closed -$259K – 1059
2022
Q1 		$259K Buy
+1,896
New +$264K 0.01% 771

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Graham Capital Management's DGX Position: Q4 2025 in Review

Graham Capital Management sold out of Quest Diagnostics (DGX) in Q4 2025, closing a stake of 3,673 shares — an estimated $700K sold.

Graham Capital Management first reported a position in DGX in Q1 2022 and held it in 4 quarters. The position peaked at $1.15M in Q2 2024. 1,048 funds tracked by Wall St. Rank hold DGX as of Q4 2025.

  • Graham Capital Management reported no remaining Quest Diagnostics position as of Q4 2025 after selling out during the quarter.
  • Graham Capital Management sold 3,673 Quest Diagnostics shares in Q4 2025, an estimated $700K.
  • Graham Capital Management first reported a position in Quest Diagnostics in Q1 2022 and held it in 4 quarters.
  • Graham Capital Management's Quest Diagnostics position peaked at $1.15M in Q2 2024.
  • 1,048 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2025.

Based on Graham Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.